CAT
Caterpillar Inc.
CAT has a slight edge over JBHT overall, supported by stronger fundamentals and stronger modeled upside.
JBHT
J.B. Hunt Transport Services, Inc.
JBHT has slightly lower modeled downside risk, despite its lower overall score.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
JBHT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
JBHT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
JBHT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 21x | $148 | -35% |
| Forward | 25x | $228 | — |
| Fair | 28x | $197 | -13% |
| Current | 32x | $228 | — |
| Expensive | 33x | $232 | +1.9% |
Historical ranges are pointers, not guarantees.
JBHT has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
JBHT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JBHT, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
JBHT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.95 | +26% |
| Q3 2026 | $7.10 | +23% |
| Q2 2026 | $7.04 | +28% |
| Q1 2026 | $6.44 | +17% |
| Q4 2025 | $6.12 | +10% |
| Q3 2025 | $5.77 | +4.9% |
| Q2 2025 | $5.50 | -5.3% |
| Q1 2025 | $5.51 | -13% |
| Q4 2024 | $5.56 | -20% |
JBHT has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over JBHT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over JBHT on profitability, with a higher operating margin.
JBHT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +20% |
| Q2 2026 | $3.5B | +19% |
| Q1 2026 | $3.1B | +4.6% |
| Q4 2025 | $3.1B | -1.6% |
| Q3 2025 | $3.1B | -0.5% |
| Q2 2025 | $2.9B | 0% |
| Q1 2025 | $2.9B | -0.8% |
| Q4 2024 | $3.1B | -4.8% |
JBHT's revenue is growing: $3.7B last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.7% | -1.2 points |
| Q2 2026 | 7.4% | +0.7 points |
| Q1 2026 | 6.8% | +0.6 points |
| Q4 2025 | 8% | +1.4 points |
| Q3 2025 | 8% | +0.7 points |
| Q2 2025 | 6.7% | -0.3 points |
| Q1 2025 | 6.1% | -0.5 points |
| Q4 2024 | 6.6% | +0.4 points |
JBHT's operating margin was 6.7% last quarter, down 1.2 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
JBHT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $219.1M | -38% |
| Q2 2026 | $253.3M | +37% |
| Q1 2026 | $242.8M | +53% |
| Q4 2025 | $251.3M | +169% |
| Q3 2025 | $352.4M | +116% |
| Q2 2025 | $185.6M | +89% |
| Q1 2025 | $158.4M | -40% |
| Q4 2024 | $93.3M | +$182.2M |
JBHT has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
JBHT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -297K shares |
| 1 year | -2.3% | -2.2M shares |
| 3 years | -9.3% | -9.7M shares |
| 5 years | -11% | -11.8M shares |
| Available history | -13% | -13.7M shares |
JBHT has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $173.8M |
| Q2 2026 | $97.8M |
| Q1 2026 | $80.1M |
| Q4 2025 | $139.9M |
| Q3 2025 | $230.4M |
| Q2 2025 | $318.8M |
| Q1 2025 | $234.1M |
| Q4 2024 | $85.6M |
JBHT spent $492M buying back its own shares over the past year, down 43% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over JBHT on leverage, with a lower net debt burden relative to earnings.
JBHT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 1.0x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.9x | Very low |
JBHT's net debt is less than a year of its operating earnings (EBITDA).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
JBHT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 7.8 | Oversold |
JBHT's weekly RSI is 43 (neutral) and its Stochastic is 8 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over JBHT on valuation relative to its sector.
JBHT PE vs Industrials Sector
| Metric | JBHT | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 24x | 33% above |
| PE % | 78 | 58 | 20 pts above |
JBHT is trading at 32x earnings, a 33% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
JBHT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $226.3 | 0.6% above |
| 20 week MA | $254.5 | 11% below |
| 50 week MA | $239.5 | 5% below |
| 100 week MA | $195.6 | 16% above |
| 200 week MA | $188.5 | 21% above |
JBHT has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
JBHT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $116.7 | $137.4 | +18% |
| 2021 | $137.4 | $197.2 | +44% |
| 2022 | $197.2 | $177.4 | -10% |
| 2023 | $177.4 | $199.7 | +13% |
| 2024 | $199.7 | $172.0 | -14% |
| 2025 | $172.0 | $198.3 | +15% |
| 2026 YTD | $198.3 | $227.7 | +15% |
JBHT has the edge over CAT on returns for 2026, with the stronger performance.